Erythropoietin
The best tips and advice from our vast library of articles, videos, and business tools
1-20 (of 113) related articles
Search Results
|
1-20 (of 113) related articles
Items per page
| |
|
1. Hospira, STADA and BIOCEUTICALS enter into agreements for erythropoietin.
Hospira (Lake Forest, IL), a leading global hospital products company, STADA Arzneimittel AG (Bad Vilbel, Germany), and BIOCEUTICALS ... (PERIODICAL ARTICLE)
2. Baxter acquires proprietary recombinant
erythropoietin.
Baxter International, Inc. (Deerfield, IL; 847-948-2349) announced that one of its subsidiaries has purchased from a small privately ... (PERIODICAL ARTICLE)
3. London High Court issues ruling in erythropoietin
patent litigation.
Transkaryotic Therapies, Inc. (Cambridge, MA; 617-349-0271) announced the High Court of Justice in London has issued an opinion ... (PERIODICAL ARTICLE)
4. A review of the first year of Medicare coverage of
erythropoietin.
BACKGROUND Pharmaceutical products developed through advances in recombinant biotechnology have been reviewed by the Food and Drug Administration ... (PERIODICAL ARTICLE)
5. Trends in Use, Cost, and Outcomes of Human Recombinant
Erythropoietin,...
INTRODUCTION EPO was the first recombinant deoxyribonucleic acid (DNA) drug to enter common medical use in the United ... (PERIODICAL ARTICLE)
6. Hematology automation aids in athletic
testing.
In keeping with standards set forth by many international sports associations, the International Cycling Union (UCI) recently tested ... (PERIODICAL ARTICLE)
7. Patent case.
Amgen Inc. sued Roche Holding AG, accusing the drug maker of infringing on six patents covering its Epogen ... (PERIODICAL ARTICLE)
8. EPO testing.
The Erythropoietin (EPO) ELISA kit is designed for the quantitative determination of EPO in human serum. The assay ... (PERIODICAL ARTICLE)
9. Amgen suit.
Amgen Suit: Johnson & Johnson has filed an antitrust suit accusing rival Amgen Inc. of using illegal leverage ... (PERIODICAL ARTICLE)
10. Quantitative EPO measurement.
The FDA-cleared Erythropoietin (EPO) ELISA kit is intended for in vitro diagnostic use, as an adjunct in determining ... (PERIODICAL ARTICLE)
11. Amgen dispute.
Investors and analysts aren't entirely sure that Amgen will be entirely successful in fighting off a threat to ... (PERIODICAL ARTICLE)
12. Transkaryotic prevails over Kirin-Amgen in House of
Lords Dynepo...
Transkaryotic Therapies, Inc. (Cambridge, MA) said that the House of Lords has ruled in favor of TKT in ... (PERIODICAL ARTICLE)
13. Valentis announces improved Geneswitch gene regulation
system.
Valentis, Inc. (Burlingame, CA; 650-697-1900) announced the publication of data detailing improvements to the company's GeneSwitch gene regulation ... (PERIODICAL ARTICLE)
14. Amgen wins patent infringement lawsuit against
Transkaryotic Therapies...
Amgen, Inc., Thousand Oaks, CA, received a favorable ruling from a federal court in its patent infringement lawsuit ... (PERIODICAL ARTICLE)
15. TKT announces victory over Amgen in
Dynepo.
Transkaryotic Therapies, Inc. (Cambridge, MA; 617-349-0271) announced that the Court of Appeal in the United Kingdom has issued ... (PERIODICAL ARTICLE)
16. US CHIRAL CHEMICALS DEMAND TO INCREASE 9.4% ANNUALLY
THROUGH THE YEAR 2005.
Combined demand for chiral chemicals -- including the value of merchant sales and captive and contract production -- ... (PERIODICAL ARTICLE)
17. Amgen Wins infringement Suit.
A federal judge ruled in favor of Amgen Inc., the world's largest biotechnology company, in a closely watched ... (PERIODICAL ARTICLE)
18. Valentis licenses technology to American Home for
functional genomics...
Valentis, Inc. (Burlingame, CA; 650-697-1900) announced that it has granted a non-exclusive license of the company's GeneSwitch gene ... (PERIODICAL ARTICLE)
19. Valentis licenses technology to Glaxo-smithkline for
functional genomics...
Valentis, Inc. (Burlingame, CA; 650-697-1900) announced that it has granted a non-exclusive license of the company's GeneSwitch gene ... (PERIODICAL ARTICLE)
20. Biotech Firm Says It Is Ready to Take Off
HEADNOTE With drugs close to clinical trials, Prolong prepares to raise venture capital funds BIOTECH PROLONG PHARMACEUTICALS, INC. (PERIODICAL ARTICLE) | |
|
1-20 (of 113) related articles
Items per page
|
Medical Practices: Why a Good Accountant and Bookkeeper Are Important
Interview with Peter Lucash, AllBusiness.com's Medical Practice Advisor
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
